RBC Capital Upgrades Sage Therapeutics (SAGE) to Sector Perform Nov 21, 2024 05:23AM
RBC Downgrades Sage (SAGE) to Underperform, 'Too Much Riding On Dalza Huntington's Readout Our Analysis Shows Is High Risk' Oct 4, 2024 05:09AM
RBC Capital Issues Negative Sentiment on Sage Therapeutics (SAGE), 'we are not altogether surprised by the stock move' Apr 17, 2024 10:30AM
RBC Capital Upgrades Sage Therapeutics (SAGE) to Outperform Mar 13, 2023 06:14AM
Sage Therapeutics (SAGE) PT Lowered to $48 at RBC Capital Nov 2, 2021 01:54PM


Jun 28, 2021 06:04AM Sage Therapeutics (SAGE) PT Lowered to $60 at RBC Capital
May 4, 2021 12:52PM Sage Therapeutics (SAGE) PT Lowered to $84 at RBC Capital Following Earnings
Apr 28, 2021 06:30AM Sage Therapeutics to Present at Upcoming May Investor Conferences
Feb 25, 2021 06:55AM Sage Therapeutics (SAGE) PT Raised to $89 at RBC Capital as the Company Heads into a Tranformative Year
Jan 4, 2021 05:39AM RBC Capital Downgrades Sage Therapeutics (SAGE) to Sector Perform
Nov 30, 2020 01:16PM Sage Therapeutics (SAGE) PT Lowered to $83 at RBC Capital; Sees Sell-Off on Biogen Deal as 'Excessive'
Oct 19, 2020 11:03AM Sage Therapeutics (SAGE) WATERFALL Study Expands 'Meaningfully' - RBC
May 26, 2020 06:56AM Sage Therapeutics (SAGE) PT Raised to $75 at RBC Capital
Mar 18, 2020 09:24AM Pre-Open Movers 03/18: (VXRT) (APRN) (BNTX) Higher; (CZR) (BA) (ERI) Lower (more...)
Mar 18, 2020 06:11AM RBC Capital Upgrades Sage Therapeutics (SAGE) to Outperform
Dec 5, 2019 03:18PM RBC Capital Downgrades Sage Therapeutics (SAGE) to Sector Perform
Nov 25, 2019 06:42AM Buy Sage Therapeutics (SAGE) Ahead of Ph3 Mountain Data - RBC Capital
May 14, 2019 06:30AM Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference
Feb 20, 2019 07:22AM Sage Therapeutics (SAGE) PT Lowered to $249 at RBC Capital
Jan 7, 2019 01:03PM Sage Therapeutics (SAGE) ~45% Upside Does Not Nearly Reflect Potential Market Opportunity - RBC
Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC
Nov 5, 2018 07:09AM Sage Therapeutics (SAGE) PT Raised to $261 at RBC Capital
Oct 18, 2018 06:48AM Sage Therapeutics (SAGE) PT Raised to $259 at RBC Capital Following PPD Survey
Jun 14, 2018 12:37PM SAGE Therapeutics (SAGE) Asia Partnership Should Not Affect Potential Takeover - RBC
May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential
May 4, 2018 08:47AM Sage Therapeutics (SAGE) PT Lowered to $261 at RBC Capital
Apr 23, 2018 10:20AM Sage Therapeutics (SAGE) Weakness is a Buying Opportunity - RBC
Apr 18, 2018 01:59PM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBC
Feb 9, 2018 06:28AM SAGE Therapeutics (SAGE) Prices 3.5M Shares at $164
Dec 7, 2017 12:34PM UPDATE: Sage Therapeutics (SAGE) PT Raised to $280 at RBC Capital; Potential 'Game-Changing' Data and Takeover
Nov 9, 2017 10:47AM Sage Therapeutics (SAGE) PT Raised to $145 at RBC Capital
Nov 2, 2017 10:39AM Sage Therapeutics (SAGE) PT Raised to $120 at RBC Capital, Street High
Sep 15, 2017 02:35AM RBC Capital Starts Sage Therapeutics (SAGE) at Outperform
Aug 12, 2014 10:49AM Notable Analyst Rating Changes 08/12: (ANF) (ICUI) (DF) Upgraded; (AMCC) (WHX) (TCK) Downgraded